RhumbLine Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $4.57M | Sell |
|
|||||
|
2019
Q2 | $5.05M | Buy |
|
|||||
|
2019
Q1 | $4.83M | Buy |
|
|||||
|
2018
Q4 | $1.66M | Buy |
|
|||||
|
2018
Q3 | $1.56M | Sell |
|
|||||
|
2018
Q2 | $2.53M | Buy |
|
|||||
|
2018
Q1 | $1.73M | Sell |
|
|||||
|
2017
Q4 | $1.34M | Sell |
|
|||||
|
2017
Q3 | $2.71M | Buy |
|
|||||
|
2017
Q2 | $1.57M | Buy |
|
|||||
|
2017
Q1 | $1.21M | Buy |
|
|||||
|
2016
Q4 | $1.09M | Buy |
|
|||||
|
2016
Q3 | $1.18M | Buy |
|
|||||
|
2016
Q2 | $793K | Buy |
|
|||||
|
2016
Q1 | $245K | Buy |
|
|||||
|
2015
Q4 | $349K | Buy |
|
|||||
|
2015
Q3 | $296K | Buy |
|
|||||
|
2015
Q2 | $414K | Buy |
|